By Sheri Colberg, PhD We are continually bombarded with messages about how fat Americans have become and how bad this weight gain is for our health. Interestingly, while the United States became the fattest nation in the world during the 20th century, our average life span still increased by …
Read More »New Product: OneTouch® Delica™ Lancing System
OneTouch® Delica™ Lancing System LifeScan has introduced the new OneTouch® Delica™ Lancing System. Now available, it is designed to provide more comfortable blood glucose testing and features a 33 gauge lancet that is 40% thinner than current industry standard 28 gauge lancets. It precisely guides the lancet in a swift, …
Read More »ADA: Mortality Lower with Metformin
Metformin use may reduce mortality by 33% among patients with Type 2 diabetes who are at risk for cardiovascular events, researchers say….
Read More »ADA: Red and Processed Meat Diets May Increase Diabetes Risk
An Atkins-style diet that emphasizes animal protein may actually be linked to higher incidence of Type 2 diabetes, according to a large observational study….
Read More »ADA: Diabetes Screening Cost Effective
Screening for Type 2 diabetes in high-risk patient populations likely saves money even in the short term, researchers affirmed.…
Read More »ADA: First-in-Class Novel Drug Lowers Blood Glucose and Weight
In early trials, a novel sodium glucose co-transporter 2 (SGLT2) inhibitor appears to improve glycemic control and reduce weight among patients on metformin, researchers reported….
Read More »ADA: Red Wine Ingredient Benefits Prediabetes
Resveratrol, the compound in red wine potentially responsible for its beneficial cardiovascular effects, may also benefit patients with prediabetes, researchers say….
Read More »ADA: Diabetes and Cardiology Groups Stay Firm on Rosiglitazone
As controversy again heats up over rosiglitazone (Avandia), the American Diabetes Association (ADA) and American Heart Association (AHA) have stood firm on their positions on the embattled drug….
Read More »ADA: New and Novel DPP-4 Reduces HbA1c Alone and in Combination
A novel dipeptidyl peptidase 4 (DPP-4) inhibitor — linagliptin — showed improved glycemic control as monotherapy, as an add-on, and in combination with other oral diabetes medications, researchers reported….
Read More »ADA: New Insulin Dose Calculation Method Reduces Postprandial Hyperglycemia in Children
Children with Type 1 diabetes can have their pizza and eat it, too, if they calculate their premeal insulin dose according to carbohydrate, fat, and protein intake rather than carbohydrate intake alone, researchers reported….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.